Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
Why Are Vertex Pharmaceuticals Shares Trading Higher Today?
December 01, 2021
Tickers
VRTX
From Benzinga
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer
November 30, 2021
From Benzinga
After Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
November 30, 2021
Tickers
OLMA
From Benzinga
First Wave BioPharma Stock Jumps On Niclosamide's Favorable Safety Profile In COVID-19 Related GI Infections
November 30, 2021
Tickers
FWBI
From Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
November 30, 2021
From Benzinga
Pfizer Posts Vupanorsen Data From Mid-Stage Cardiovascular Disease Trial
November 24, 2021
From Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
From Benzinga
Imara Changes Primary Endpoint In Mid-Stage Sickle Cell Disease Trial
November 22, 2021
Tickers
IMRA
From Benzinga
Jaguar Health's Posts Crofelemer Data For Chemo-Induced Diarrhea In Breast Cancer Patients
November 19, 2021
Tickers
JAGX
From Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
From Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
November 19, 2021
Tickers
ASND
From Benzinga
From Benzinga
From Benzinga
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
November 15, 2021
Tickers
NVCR
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Adaptimmune Bullish On Meeting Endpoint For Soft Tissue Cancer Trial
November 11, 2021
Tickers
ADAP
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.